Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Genentech, Inc. (NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Stories about Genentech, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Monday's biggest gaining and declining stocks
March 09, 2009
Among the companies whose shares are expected to see active trade in Monday's session are AT&T, Elan, Genta, McClatchy, Merck, Northrop Grumman, Schering-Plough, Sterlite, Vedanta and Watson Pharma. Read More
category GNTA , UK:LLOY , T , and 28 more.
from MarketWatch
Weekly Outlook: March 9, 2009
March 08, 2009
Another week of financial shrapnel and disappointing economic data set the stage for a strongly oversold platform entering Monday. Read More
from Optionetics
Roche Increases Tender Offer For Genentech
March 06, 2009
Roche increased its hostile tender offer for Genentech Inc. (NYSE: DNA) to $93 per share after its initial bid of $86.50 failed to generate shareholder interest.  The stock price surged $9.22 to close... Read More
from MarketMinute.com Stock News
Consumer Borrowing Up, Markets Close Mixed
March 06, 2009
It was a mixed close for the markets with the Dow gaining 33 points to 6627 as consumer borrowing unexpectedly climbed in January and the nation's unemployment rate surged. Nasdaq lost 6 points to... Read More
category Market News
from MarketMinute.com Market Updates
Roche Raises Price in Hostile Offer for Genentech
March 06, 2009
Swiss drug developer Roche boosted its hostile tender offer for biotechnology pioneer Genentech Inc. to $93 per share Friday, raising the total offer value to about $45 billion, after its initial offer... Read More
category Health Care
from FOXBusiness.com
Genentech faces new buyout bid; GM shares may see evening action
March 06, 2009
Shares of General Motors Corp. may be active Friday evening as government officials discuss the next move for the automaker, and Genentech Inc. shares may attract attention with a new buyout offer for... Read More
category F , Market News , Markets/Exchanges , and 5 more.
from MarketWatch
Genentech Advises Shareholders Not To Act On New Roche Offer
March 06, 2009
Genentech Advises Shareholders Not To Act On New Roche Offer Read More
category Health Care
from FOXBusiness.com
Genentech (DNA) Special Committee Urges Shareholders to Take No Action Related to Revised Offer from Roche
March 06, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4466561 for the full story. Read More
from StreetInsider.com News Articles
Genentech Jumps on Roche’s Raised Offer (DNA)
March 06, 2009
Shares of Genentech (DNA) are currently up 9% after the biotech giant received an increased offer of $93 following Roche’s recently lowered offer of $86.50. Roche already owns about 56% of Genentech’s... Read More
category TOP STORY , dna , Non/Dividend Stocks
from Dividend Daily
Roche raises bid for Genentech to $93 a share
March 06, 2009
Swiss conglomerate Roche says that it has raised its offer to acquire the shares of Genentech Inc. that it does not already own to $93 a share from $86.50 a share. Read More
category Market News , Company Announcements , Pharmaceuticals , and 4 more.
from MarketWatch
Midday Action: March 6
March 06, 2009
Early better-than-feared cheer is no match for a little "tech wreck" action and a "not-so-goog" Friday. Read More
from Optionetics
Roche Raises Bid For Genentech To $93 a Share
March 06, 2009
Roche Raises Bid For Genentech To $93 a Share Read More
category Health Care
from FOXBusiness.com
Roche Raises Offer for Genentech (DNA) to $93/Share
March 06, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4466081 for the full story. Read More
from StreetInsider.com News Articles
Roche increases offer for Genentech (DNA) to $93/share -Bloomberg
March 06, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4466065 for the full story. Read More
from StreetInsider.com News Articles
Genentech (DNA) NewsBite - Trading With Unusual Volume
March 06, 2009
Genentech (DNA) appears to be trading at a higher than usual volume today and is now at $90.03, up $8.39 (10.28%) on volume of 27,821,400 shares traded. For the last 30 days DNA has traded... Read More
category DNA
from MarketIntelligenceCenter.com
Genentech (DNA) PriceWatch Alert For 3/6/2009 - Calendar Spread Risk Ranking Improves to 2 Keys
March 06, 2009
Genentech (NYSE: DNA) closed yesterday at $81.64. So far the stock has hit a 52-week low of $66.80 and 52-week high of $99.14. The proprietary Key Risk Ranking for DNA has improved from a 1...(Click... Read More
category DNA
from MarketIntelligenceCenter.com
Genentech (DNA) PriceWatch Alert For 3/6/2009 - Covered Call Risk Ranking Declines to 3 Keys
March 06, 2009
Genentech (NYSE: DNA) closed yesterday at $81.64. So far the stock has hit a 52-week low of $66.80 and 52-week high of $99.14. The proprietary Key Risk Ranking for DNA has declined from a ...(Click the... Read More
category DNA
from MarketIntelligenceCenter.com
Option Watch: March 3â??All Bulled Up or Bugged Out?
March 03, 2009
Another "Gold Fly" appears to be hard at work as other bulls continue to bug out. Read More
from Optionetics
Europe shares bounce off lows behind banks, pharmas
March 03, 2009
European shares on Tuesday bounced back a bit after the pounding that took markets to nearly six-year lows, as banks took back a portion of the previous sessionâ??s heavy losses and drug makers also... Read More
category UK:STAN , General News , Financial Services , and 24 more.
from MarketWatch
Genentech (DNA) volatility Flat into Investor day and Roche tender
March 02, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4447225 for the full story. Read More
from StreetInsider.com News Articles
Roche Sells Largest Amount Of Euro Bonds Ever
February 25, 2009
Roche Sells Largest Amount Of Euro Bonds Ever Read More
category Health Care
from FOXBusiness.com
Apple shareholders re-elect board despite disclosure concerns
February 25, 2009
Shareholders vote to re-elect the companyâ??s board of directors despite concerns related to the disclosure, or lack thereof, about CEO Steve Jobs. Read More
category Market News , SEC , DNA , and 6 more.
from MarketWatch
Morning Watch, February 24
February 24, 2009
Stocks see higher prices to start the session, but this could change following speech by Fed Chairman Bernanke. Read More
from Optionetics
Notable Mergers and Acquisitions of the Day 2/24: DNA, EXAR/HIFN, INSU, JUPM
February 24, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4430582 for the full story. Read More
from StreetInsider.com News Articles
Home Depot, J.P. Morgan, Macy's in the spotlight
February 24, 2009
U.S. stock market futures edged higher Tuesday, following heavy losses in the previous session, as investors looked ahead to testimony from Federal Reserve Chairman Ben Bernanke. Read More
category HNZ , Earnings , Retail , and 13 more.
from MarketWatch
Tuesday's biggest gaining and declining stocks
February 24, 2009
Among the companies whose shares are expected to see active trade in Tuesdayâ??s session are AIG, Basilea, Genentech, HealthSouth, Hertz, Home Depot, MAP Pharma, Medco, Nordstrom and RadioShack. Read More
category JWN , BPMUF , AFL , and 30 more.
from MarketWatch
Genentech (DNA) PriceWatch Alert For 2/24/2009 - Covered Call Risk Ranking Declines to 3 Keys
February 24, 2009
Genentech (NYSE: DNA) closed yesterday at $84.55. So far the stock has hit a 52-week low of $66.80 and 52-week high of $99.14. The proprietary Key Risk Ranking for DNA has declined from a ...(Click the... Read More
category DNA
from MarketIntelligenceCenter.com
Stocks In Focus For Tuesday
February 23, 2009
Stocks In Focus For Tuesday Read More
category Retail
from FOXBusiness.com
Stocks in focus for Tuesday
February 23, 2009
Among the companies whose shares are expected to see active trade in Tuesdayâ??s session are Target, Home Depot and Macyâ??s. Read More
category JWN , Earnings , Biotechnology , and 31 more.
from MarketWatch
Genentech Rejects Roche Offer
February 23, 2009
U.S. biotechnology giant Genetech (DNA) spurned a bid from Roche to buy the remaining shares of the firm it does not already own for $43.7 billion. Read More
category Technology
from FOXBusiness.com
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here